, Volume 137, Issue 9, pp 1379-1396

Chinese guidelines for the diagnosis and comprehensive treatment of hepatic metastasis of colorectal cancer

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access
This is an excerpt from the content

Part one guidelines for diagnosis and treatment

The liver is the most common anatomical site for hematogenous metastases of colorectal cancer (Foster 1984; Fong et al. 1997), and hepatic metastases are one of the most difficult and challenging points in the treatment of colorectal cancer. Hepatic metastases are found among 15–25% of patients suffering from colorectal cancer at the time of primary diagnosis. Another 25–35% of patients will be found after apparently curative radical excision has been performed for the primary tumor. Most of these patients (about 80–90%) will not be suitable candidates for radical excision of their hepatic metastases. Hepatic metastases are therefore the most common cause of death for colorectal cancer patients (Foster 1984; Vibert et al. 2005; Kemeny 2006; Lau and Lai 2007; Taniai et al. 2007; Arru et al. 2008). The median survival time for patients with untreated hepatic metastases is only 6.9 months, with a 5-year survival rate of 0% (Sharma et al. 2008